DocuSign, Inc. (NASDAQ:DOCU) Shares Sold by Brighton Jones LLC

Brighton Jones LLC trimmed its holdings in DocuSign, Inc. (NASDAQ:DOCU) by 24.0% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 10,071 shares of the company’s stock after selling 3,188 shares during the period. Brighton Jones LLC’s holdings in DocuSign were worth $625,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also recently added to or reduced their stakes in the business. International Assets Investment Management LLC grew its stake in DocuSign by 5,660.8% in the 3rd quarter. International Assets Investment Management LLC now owns 438,914 shares of the company’s stock valued at $27,252,000 after acquiring an additional 431,295 shares during the last quarter. Lecap Asset Management Ltd. grew its stake in DocuSign by 312.3% in the 3rd quarter. Lecap Asset Management Ltd. now owns 52,858 shares of the company’s stock valued at $3,282,000 after acquiring an additional 40,037 shares during the last quarter. Castleview Partners LLC grew its stake in DocuSign by 4,530.0% in the 3rd quarter. Castleview Partners LLC now owns 1,389 shares of the company’s stock valued at $86,000 after acquiring an additional 1,359 shares during the last quarter. Allspring Global Investments Holdings LLC grew its stake in DocuSign by 2,194.6% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 105,688 shares of the company’s stock valued at $6,562,000 after acquiring an additional 101,082 shares during the last quarter. Finally, DMC Group LLC grew its stake in DocuSign by 4.6% in the 3rd quarter. DMC Group LLC now owns 4,561 shares of the company’s stock valued at $283,000 after acquiring an additional 201 shares during the last quarter. 77.64% of the stock is owned by institutional investors and hedge funds.

Insider Activity at DocuSign

In related news, CFO Blake Jeffrey Grayson sold 9,552 shares of the firm’s stock in a transaction that occurred on Tuesday, October 15th. The shares were sold at an average price of $68.80, for a total value of $657,177.60. Following the transaction, the chief financial officer now owns 78,265 shares in the company, valued at approximately $5,384,632. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. In other news, Director Daniel D. Springer sold 70,983 shares of the business’s stock in a transaction on Monday, August 5th. The shares were sold at an average price of $49.84, for a total transaction of $3,537,792.72. Following the transaction, the director now directly owns 891,373 shares of the company’s stock, valued at approximately $44,426,030.32. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CFO Blake Jeffrey Grayson sold 9,552 shares of the business’s stock in a transaction on Tuesday, October 15th. The stock was sold at an average price of $68.80, for a total transaction of $657,177.60. Following the transaction, the chief financial officer now directly owns 78,265 shares in the company, valued at approximately $5,384,632. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 427,554 shares of company stock worth $23,129,150. Company insiders own 1.66% of the company’s stock.

DocuSign Stock Performance

DOCU opened at $68.99 on Friday. The company’s 50 day simple moving average is $61.87 and its 200 day simple moving average is $57.66. DocuSign, Inc. has a 1 year low of $38.11 and a 1 year high of $73.80. The stock has a market capitalization of $14.12 billion, a PE ratio of 132.67, a P/E/G ratio of 7.33 and a beta of 0.92.

DocuSign (NASDAQ:DOCU) last posted its quarterly earnings results on Thursday, September 5th. The company reported $0.97 EPS for the quarter, beating the consensus estimate of $0.80 by $0.17. DocuSign had a net margin of 34.56% and a return on equity of 16.18%. The firm had revenue of $736.03 million for the quarter, compared to analyst estimates of $727.20 million. During the same quarter last year, the firm posted $0.09 earnings per share. DocuSign’s revenue for the quarter was up 7.0% compared to the same quarter last year. As a group, sell-side analysts expect that DocuSign, Inc. will post 1.01 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on DOCU. Needham & Company LLC reaffirmed a “hold” rating on shares of DocuSign in a research note on Friday, September 6th. Bank of America raised their price target on shares of DocuSign from $60.00 to $68.00 and gave the stock a “neutral” rating in a research note on Friday, September 6th. Wells Fargo & Company raised their price target on shares of DocuSign from $48.00 to $50.00 and gave the stock an “underweight” rating in a research note on Friday, September 6th. Robert W. Baird raised their price target on shares of DocuSign from $55.00 to $59.00 and gave the stock a “neutral” rating in a research note on Friday, September 6th. Finally, JMP Securities reaffirmed a “market outperform” rating and set a $84.00 price target on shares of DocuSign in a research note on Thursday, September 5th. Two analysts have rated the stock with a sell rating, seven have given a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat, DocuSign has a consensus rating of “Hold” and a consensus price target of $63.40.

About DocuSign

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.